Guided Bone Regeneration in Alveolar Socket (GBR_socket)

October 16, 2024 updated by: Danae A. Apatzidou, Aristotle University Of Thessaloniki

Guided Bone Regeneration in Alveolar Socket Using a Synthetic Resorbable Membrane. a Randomized Controlled Trial

Following tooth extraction, volumetric changes in the soft and hard tissues of the extraction site are expected to occur with considerable resorption of the alveolar bone in both the vertical and the horizontal dimensions. These changes may complicate surgical implant placement and may also compromise the outcome of the prosthetic reconstruction. Various treatment approaches have been introduced aiming to preserve the dimensions of the alveolar ridge at the extraction site and facilitate optimal implant placement.

This prospective randomized controlled trial aims to determine the efficacy of alveolar ridge preservation utilizing two different socket seal approaches compared to spontaneous healing to stabilize the blood clot within the postextraction socket. Thirty-six subjects will be randomly allocated into one of the three treatment groups. Group-A: Extraction of the tooth and suturing of the extraction socket with resorbable suture PGA 5/0. Group-B: Extraction of the tooth and placement of a Free Gingival Graft stabilized with resorbable suture PGA 5/0. Group-C: Extraction of the tooth and placement of the Polylactic-Glycolic Acid membrane stabilized with resorbable suture PGA 5/0. After the initial examination for screening, subjects will be assessed at baseline-extraction day- and after 1, 2, and 6 weeks, and 3 months. The changes of the alveolar crest will be determined in height and width, in addition to volumetric changes in the soft tissues, and the width of keratinized tissues. The wound healing process will be visually assessed.

Study Overview

Detailed Description

This prospective randomized controlled trial aims to determine the effectiveness of two different approaches of the "socket seal technique" for the preservation of the soft and hard tissues at the extraction site by utilizing a free gingival graft (FGG) or a PLGA membrane to stabilize the blood clot within the extraction socket compared with spontaneous healing of the tissues.

Primary outcome variable of the study will be alveolar bone changes in height buccally and palatally.

Secondary outcome variables: Alveolar bone changes in width, Mucosa thickness changes, Wound healing visual assessment, Width of keratinized tissues.

Materials and methods Thirty-six subjects will be randomly allocated into one of the three treatment groups based on computer-generated lists using a "block-design". Each patient contributes with one study site.

Study groups:

Group-A: Extraction of the tooth and suturing of the extraction socket with resorbable suture PGA 5/0.

Group-B: Extraction of the tooth, deepithelialization of the gingival colar of the socket, placement of a Free Gingival Graft taken from a standardized location of the palate adjusted to seal the socket opening and then stabilize it by resorbable suture PGA 5/0.

Group-C: Extraction of the tooth, retraction of mucoperiosteal flaps by 2 mm at the opening of the socket using a microsurgical elevator followed by adjustment of the Polylactic-Glycolic Acid membrane over the socket opening resting by 1 mm over the alveolar crest of the extraction socket. Tissues are sutured over the barrier by resorbable suture PGA 5/0.

Timeline of the study/Clinical procedures:

First visit - initial examination - (1 week before the surgery)

  • Suitability of subjects
  • Consent form; Randomization of the patient
  • Radiographic examination (Long-cone paralleling technique using a digital sensor attached to a custom-made silicone bite block for reproducible radiographs)
  • Intra-oral photography
  • Impression of the examined area in order to create a reference stent to reproduce in a standard manner the clinical/radiographic measurements.
  • Full mouth scaling; oral hygiene instructions

Second visit - Baseline - T0

  • Clinical measurements with the use of the reference stent of:

    (i) The width of keratinized tissues with the use of a periodontal probe (Hu-Friedy XP-23/QW) (ii) The thickness of mucosa with the use of an ultrasonic device SDM (iii) The buccal osseous plate in relation to the gingival margin with a periodontal probe.

  • Extraction of the tooth in a standardized way to minimize trauma; Post-surgical instructions will be given to the patient. Treatment of the extraction site accordingly to randomized treatment approach (Group-A, -B, -C).

    (i) Radiographic examination: (ii) Standardized intraoral x-ray and standardized CBCT (with the use of a reference stent)

Third visit - T1 - (1 week after the surgery)

  • Evidence of healing
  • Intra-oral photography

Fourth visit - T2 - (2 weeks after the surgery)

  • Evidence of healing
  • Removal of sutures
  • Intra-oral photography

Fifth visit - T3 - Re-evaluation (6 weeks after the surgery)

  • Intra-oral photography
  • Width of keratinized tissues with the use of periodontal probe (Hu-Friedy XP-23/QW)
  • Thickness of mucosa determined by the ultrasonic device SDM in the aforementioned standardized points with the use of the reference stent.
  • Radiographic examination (The long-cone paralleling technique will be used at a distance of 10 cm between the X-ray head and the digital sensor which is attached to a custom-made silicone bite block for reproducible radiographs.)

Sixth visit - T4 - Final evaluation (3 months after the extraction)

  • Intra-oral photography
  • Record of periodontal plaque index (Pl) and bleeding on probing (BoP) at the adjacent teeth with the use of periodontal probe (Hu-Friedy XP-23/QW).
  • Record of the width of keratinized tissues with the use of periodontal probe (Hu-Friedy XP-23/QW) and the thickness with the use of the ultrasonic device SDM in the aforementioned standardized points with the use of the reference stent.
  • Radiographic examination with standardized intraoral x-ray and CBCT (with the use of the reference stent)

Study Type

Interventional

Enrollment (Estimated)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Thessaloniki, Greece, 54124
        • Recruiting
        • Dental School, Aristotle University, Dept of Preventive Dentistry, Periodontology and Implant Biology
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Referrals for a single tooth extraction
  • Periodontal destruction less than 50% of tooth support
  • Signed inform consent form

Exclusion Criteria:

  • Systematic diseases, contradicting surgical procedures and compromise wound healing (i.e. uncontrolled diabetes)
  • Medication that interferes with bone metabolism
  • Pregnancy or lactation
  • Multiple extractions
  • Absence of adjacent teeth
  • Loss of buccal bone, either due to periodontal disease or because of traumatic extraction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Spontaneous healing
Routine treatment of the extraction socket. Extraction of the tooth and suturing of the extraction socket with resorbable suture PGA 5/0 (polygalactic acid 5/0 sutures; PGA, medipac, Greece).
Suturing of the extraction socket with resorbable suture PGA 5/0 in order to protect the blood clot
Active Comparator: Free gingival graft
Extraction of the tooth, placement of a Free Gingival Graft taken from the palate and adjusted to seal the socket opening and stabilize it by resorbable sutures PGA 5/0 (polygalactic acid 5/0 sutures; PGA, medipac, Greece).
Placement of a free gingival graft in the socket opening in order to protect and stabilize the blood clot followed by suturing
Experimental: Polylactic-Glycolic Acid membrane
Extraction of the tooth, adjustment of the Polylactic-Glycolic Acid membrane (PLGA,Tisseos®, Biomedical Tissues, Septodont, France) over the socket opening resting by 1 mm over the alveolar crest of the extraction socket. Tissues are sutured over the barrier by resorbable sutures PGA 5/0 (polygalactic acid 5/0 sutures; PGA, medipac, Greece).
Placement of a synthetic barrier in the socket opening in order to protect and stabilize the blood clot followed by suturing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Osseous changes in height of the alveolar ridge
Time Frame: Clinically: immediately after tooth extraction(baseline), 6 weeks and 3 months after the extraction. CBCT: immediately after the extraction and 3 months after the extraction
The height of the alveolar ridge will be measured at standardized points distal, mesial and buccal/ palatal/ lingual at standardized points with the use of a reference stent by a CBCT.
Clinically: immediately after tooth extraction(baseline), 6 weeks and 3 months after the extraction. CBCT: immediately after the extraction and 3 months after the extraction
Osseous changes in width of the alveolar ridge
Time Frame: Immediately after the extraction(baseline) and 3 months after the extraction
The width of the alveolar ridge will be measured distal, mesial and buccal/ palatal/ lingual at standardized points with the use of a reference stent by a CBCT.
Immediately after the extraction(baseline) and 3 months after the extraction

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mucosa thickness changes
Time Frame: Baseline, 6 weeks and 3 months after the extraction
The thickness of the keratinized tissues will be determined with the use of an ultrasonic device SDM (Austenal Medizintechnik, Koln, Germany) for recording soft tissue thickness at standardized points with the use of a reference stent.
Baseline, 6 weeks and 3 months after the extraction
Width of keratinized tissues
Time Frame: Baseline, 6 weeks and 3 months after the extraction
The width of the keratinized tissues will be determined on the buccal aspect by a manual periodontal probe (Hu-Friedy XP-23/QW) in a standardized way by the use of a reference stent at three time-points. All recordings will be transferred to a digital caliber
Baseline, 6 weeks and 3 months after the extraction
Wound healing
Time Frame: 1 and 2 weeks after the extraction
Visual assessment of healing
1 and 2 weeks after the extraction

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Actual)

March 30, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

October 10, 2022

First Submitted That Met QC Criteria

October 10, 2022

First Posted (Actual)

October 13, 2022

Study Record Updates

Last Update Posted (Actual)

October 17, 2024

Last Update Submitted That Met QC Criteria

October 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Overall data but not on an individual basis will be disclosed and shared

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alveolar Bone Resorption

Clinical Trials on Routine treatment of the extraction socket

Subscribe